Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham et al. · The Lancet · 2017 · 1.2K citations · Full text

Medicine, Dermatology, Immunology +17

Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis

Margitta Worm, Eric L. Simpson, Diamant Thaçi et al. · JAMA Dermatology · 2019 · 206 citations · Full text

Life Sciences, Dermatology, Pharmacotherapy +10

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study

Cataldo Patruno, Maddalena Napolitano, Giuseppe Argenziano et al. · Journal of the European Academy of Dermatology and Venereology · 2020 · 96 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis

Maria Concetta Fargnoli, Maria Esposito, Silvia Mariel Ferrucci et al. · Journal of Dermatological Treatment · 2019 · 93 citations · Full text

Life Sciences, Dermatology, Pharmacotherapy +17

Risk versus benefit or risk versus risk: Risk aversion in the medical decision making process

Elias Oussedik, Michael S. Anderson, Steven R. Feldman · Journal of Dermatological Treatment · 2017 · 30 citations · Full text

Business, Decision Sciences, Decision Analysis +11